03.07.2014 - British Ario Pharma Ltd has strengthened its scientific capacities by adding two research experts to its team.
The Cambridge-based respiratory disease specialist has appointed Peter Barnes and Wisia Wedzichato its Scientific Advisory Board. The current President of the European Respiratory Society, Barnes has published more than 1,000 peer-review papers on asthma and chronic obstructive pulmonary disease (COPD). The most highly-cited respiratory researcher in the world over the last 20 years also co-founded RespiVert (now Johnson & Johnson). Wedzicha is a member of the Guideline Development Group for the revision of the NICE COPD guidelines, and has a particular interest in the causes, mechanisms, impact and prevention of COPD exacerbations and the role bacterial and viral infections play in them. She directs an active research group in that area and has published extensively on the topic.